In addition, the frequency of tumors with a mixed differentiated and poorly differentiated adenocarcinoma component was statistically higher for CRA than for CDA (24/51, 47.1% vs. 17/126, 13.5%; P <  0.01). The gene discussed is CDA; the disease is adenocarcinoma.